Medical Robotics and Computer-Assisted Surgery Market to Reach US$ 26.02 Billion by 2035 as AI-Enabled Surgical Systems Improve Precision, Workflow Efficiency and Patient Outcomes

The global medical robotics and computer-assisted surgery market reached US$10.50 billion in 2025 and is projected to reach US$26.02 billion by 2035, expanding at a CAGR of 9.5% during 2026-2035, according to DataM Intelligence. Growth is increasingly tied to how hospitals evaluate surgical robots as productive clinical infrastructure rather than isolated capital equipment. The investment case now connects minimally invasive capacity, procedure consistency, operating-room utilization and the ability to expand advanced surgery across more specialties.

Request Executive Sample | Market Intelligence: https://www.datamintelligence.com/download-sample/medical-robotics-and-computer-assisted-surgery-market?kailas

2026 Official Developments in Surgical Robot Launches, Procedure Expansion, Clearances and Hospital Installations

1. Intuitive expanded the clinical reach of da Vinci 5. In January 2026, the company announced US FDA clearance to use the platform in certain cardiac procedures, widening its addressable procedure base beyond established soft-tissue applications.

2. Medtronic moved Hugo into US commercial deployment. In February, the first commercial US procedure using the Hugo robotic-assisted surgery system was completed at Cleveland Clinic. Duke University Hospital and Atrium Health Wake Forest Baptist High Point Medical Center were also identified among the first US installations, demonstrating the system's transition from clinical study to commercial use.

3. Stryker introduced a handheld robotics model. The February limited-market release of Mako RPS for Total Knee combined intraoperative planning with a robotically enabled saw and targeted surgeons seeking robotic guidance within a familiar power-tool workflow. Stryker reported that Mako platforms had supported more than two million procedures across 46 countries.

4. Zimmer Biomet expanded robotic shoulder surgery capabilities. In May, the company received US FDA 510(k) clearance for an advanced ROSA Shoulder System supporting robotically assisted glenoid preparation and humeral resection for anatomic and reverse shoulder arthroplasty.

5. Medtronic and Asan Medical Center formed a strategic robotics partnership. Their 2026 agreement covers Hugo-related clinical research, education and technology development, reinforcing the importance of hospital partnerships in building evidence, training capacity and regional adoption.

Surgical Capacity Is Becoming the Core Investment Metric

Medical robotics and computer-assisted surgery combine robotic hardware, imaging, navigation, software and analytics to help surgical teams perform procedures with greater control and repeatability.

The central investment question is no longer whether a system can improve precision. Hospitals must determine whether the platform can support enough procedures, specialties and trained teams to justify its acquisition, service, instrument and integration costs.

A productive robotics program requires:
- A dependable pipeline of suitable procedures
- Credentialed surgeons and trained operating-room teams
- High system availability and technical support
- Efficient setup, room turnover and scheduling
- Reliable access to instruments and consumables
- Measurable clinical and operational outcomes

Systems capable of supporting several specialties through a shared digital environment have a stronger route to high utilization than narrowly deployed assets.

Procurement is consequently shifting toward total program economics. Evaluations increasingly include system uptime, disposable consumption, service contracts, training time, room turnover, length of stay, revision risk and revenue generated through additional minimally invasive procedures.

Request a Customized Report According to Your Business Strategy: https://www.datamintelligence.com/customize/medical-robotics-and-computer-assisted-surgery-market?kailas

Minimally Invasive Demand Meets Digital Operating-Room Integration

Minimally invasive surgery remains the principal demand engine because robotic and computer-assisted systems can improve visualization, instrument control and access within confined anatomy.

Population aging adds another layer of demand, particularly for joint replacement and the surgical treatment of urological, cardiovascular and neurological conditions. The World Health Organization projects that the global population aged 60 and above will increase to approximately 1.4 billion by 2030.

Digital operating-room integration is also becoming an important differentiator. Advanced platforms increasingly connect:
- Preoperative imaging and patient-specific planning
- Intraoperative navigation and visualization
- Robotic instruments and energy devices
- Procedure recording and performance analytics
- Remote observation and clinical collaboration
- Postoperative data and outcome monitoring

This integration enables hospitals to assess the complete surgical pathway rather than purchasing the robot as a standalone machine.

Adoption nevertheless remains constrained by capital requirements, recurring instrument expenses, maintenance costs, operating-room space and the time needed to train entire teams. Evidence must also remain procedure-specific. The US FDA states that robotically assisted surgery can be safe and effective for certain procedures when used appropriately and with proper training, emphasizing that system clearance does not replace surgeon experience, credentialing or outcome monitoring.

Orthopedics and Soft-Tissue Surgery Present Different Economics

DataM Intelligence identifies medical robots as the largest product category, hardware as the leading component, hospitals as the dominant end-user segment and orthopedic surgery as the fastest-growing application. The market also includes computer-assisted surgical systems, software and services, with ambulatory surgical centers becoming increasingly important as compact systems and minimally invasive procedures move beyond large academic hospitals.

Orthopedics offers attractive installed-base economics because knee, hip, spine and shoulder workflows can combine robotic guidance with implants, planning software and recurring services.

Urology remains a mature entry point for soft-tissue robotics, while general surgery provides a large procedure pool for future indication expansion. Neurosurgery rewards high-accuracy navigation and imaging integration. Ambulatory surgical centers create an opportunity for smaller-footprint systems capable of demonstrating fast setup, predictable utilization and manageable per-procedure costs.

Regional Adoption Reflects Infrastructure and Evidence Pathways

The USA remains the leading commercial market, supported by established robotics programs, academic hospitals, regulatory pathways and a large base of trained surgeons. Initial 2026 Hugo installations and continued da Vinci procedure expansion demonstrate the importance of clinical networks in accelerating adoption.

Japan combines an aging population with an established PMDA review and consultation framework for advanced medical devices. Successful market access therefore depends on local clinical evidence, regulatory planning, training and post-market support.

Within Europe, Germany offers an important hospital and medical-technology environment, while DataM Intelligence identifies the wider European region as the fastest-growing market through 2035.

South Korea is strengthening its advanced medical-device ecosystem through public research investment and hospital-industry collaboration. Its health ministry announced new 2026 medical-device research programs, while the Asan-Medtronic partnership positions the country as an important center for robotic-surgery research and education.

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=medical-robotics-and-computer-assisted-surgery-market?kailas

Major Platforms Are Competing on Utilization, Not Hardware Alone
Intuitive Surgical

Intuitive anchors the soft-tissue segment through its da Vinci portfolio and extensive training, instrument and service ecosystem. In May 2026, the company reported more than 1,400 da Vinci 5 installations and over 380,000 procedures on the platform. It also announced telepresence, simulation, workflow, reliability and instrument-use enhancements. Its advantage lies in combining installed scale with procedural expansion and recurring revenue.

Medtronic

Medtronic is positioning Hugo within a connected operating-room offering spanning open, laparoscopic and robotic procedures. Its modular architecture, initial US hospital installations and planned expansion beyond urology indicate a strategy centered on flexibility, hospital choice and cross-modality integration.

Stryker

Stryker's Mako portfolio connects robotics with orthopedic implants, CT-based planning, haptic guidance and procedural data. The introduction of Mako RPS extends its reach from robotic-arm systems into handheld robotics, potentially broadening adoption across hospitals and other sites of care.

Zimmer Biomet

Zimmer Biomet integrates ROSA robotics with implants, ZBEdge analytics and digital care-management tools. Its expansion from knee into shoulder applications demonstrates how orthopedic companies can increase platform value by covering more joints and connecting preoperative, intraoperative and postoperative information.

Capital Planning Will Determine the Next Market Leaders

The medical robotics market will reward platforms that convert technical precision into repeatable procedural and financial performance. Hospitals are likely to favor systems with broad indication potential, dependable uptime, scalable training, manageable per-case costs and credible evidence of clinical value.

The strongest capital plans will therefore begin with the procedure portfolio-not the machine. Installed-base growth alone will not define commercial success. Utilization, specialty expansion, service economics and integration into the digital operating room will determine which robotic surgery systems become durable healthcare infrastructure.

Read Exclusive Report Description: https://www.datamintelligence.com/research-report/medical-robotics-and-computer-assisted-surgery-market

Contact:
Fabian Mathew
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: fabian@datamintelligence.com

About DataM Intelligence
DataM Intelligence is a global market research and business intelligence firm delivering actionable insights across healthcare, pharmaceuticals, chemicals, energy, technology, food, and industrial sectors. Through syndicated reports, custom research, consulting, and competitive intelligence services, the company helps organizations identify growth opportunities, navigate market challenges, and make informed strategic decisions in over 50+ countries worldwide.

This release was published on openPR.